Growth Metrics

Pfizer (PFE) Assets Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -0.01%
Dec 31, 2025 -2.45%
Sep 28, 2025 -4.77%
Jun 29, 2025 -4.67%
Mar 30, 2025 -5.91%
Dec 31, 2024 -5.79%
Sep 29, 2024 2.08%
Jun 30, 2024 -1.81%
Mar 31, 2024 13.02%
Dec 31, 2023 14.98%
Oct 1, 2023 422.64%
Jul 2, 2023 12.74%
Apr 2, 2023 6.31%
Dec 31, 2022 8.55%
Oct 2, 2022 -11.22%
Jul 3, 2022 14.93%
Apr 3, 2022 15.86%
Dec 31, 2021 17.67%
Oct 3, 2021 3.02%
Jul 4, 2021 -4.50%
Apr 4, 2021 -4.52%
Dec 31, 2020 -7.97%
Sep 27, 2020 -2.40%
Jun 28, 2020 13.91%
Mar 29, 2020 7.02%
Dec 31, 2019 5.41%
Sep 29, 2019 -72.54%
Jun 30, 2019 -5.32%
Mar 31, 2019 -5.58%
Dec 31, 2018 -7.56%
Sep 30, 2018 -2.51%
Jul 1, 2018 -2.38%
Apr 1, 2018 -2.47%
Dec 31, 2017 0.22%
Oct 1, 2017 -3.52%
Jul 2, 2017 -0.97%
Apr 2, 2017 3.59%
Dec 31, 2016 2.76%
Oct 2, 2016 4.43%
Jul 3, 2016 6.08%
Apr 3, 2016 1.42%
Dec 31, 2015 -0.34%
Sep 27, 2015 -0.29%
Jun 28, 2015 -6.80%
Mar 29, 2015 -6.50%
Dec 31, 2014 -2.64%
Sep 28, 2014 -2.37%
Jun 29, 2014 -3.75%
Mar 30, 2014 -8.32%
Dec 31, 2013 -7.37%
Sep 29, 2013 -3.88%
Jun 30, 2013 -1.92%
Mar 31, 2013 0.92%
Dec 31, 2012 -1.17%
Sep 30, 2012 -6.90%
Jul 1, 2012 -6.67%
Apr 1, 2012 -4.76%
Dec 31, 2011 -3.60%
Oct 2, 2011 2.46%
Jul 3, 2011 2.53%
Apr 3, 2011 -0.08%
Dec 31, 2010 -8.42%
Oct 3, 2010 35.47%
Jul 4, 2010 37.13%